相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evolving Therapies for Myocardial Ischemia/Reperfusion Injury
Borja Ibáñez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Nod-Like Receptor Protein-3 Inflammasome Plays an Important Role during Early Stages of Wound Healing
Eileen M. Weinheimer-Haus et al.
PLOS ONE (2015)
Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
Stefano Toldo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies
Sandrine Lecour et al.
CARDIOVASCULAR RESEARCH (2014)
NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
Masafumi Takahashi
INTERNATIONAL HEART JOURNAL (2014)
Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression
Willeke M. C. Jong et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia-Reperfusion in the Mouse
Carlo Marchetti et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemiareperfusion injury
Oystein Sandanger et al.
CARDIOVASCULAR RESEARCH (2013)
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Derek J. Hausenloy et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Blocking Interleukin-1 as a Novel Therapeutic Strategy for Secondary Prevention of Cardiovascular Events
Antonio Abbate et al.
BIODRUGS (2012)
The innate immune response in reperfused myocardium
Leo Timmers et al.
CARDIOVASCULAR RESEARCH (2012)
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Ph. Gabriel Steg et al.
EUROPEAN HEART JOURNAL (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling
Coert J. Zuurbier et al.
PLOS ONE (2012)
Abdominal Surgical Incision Induces Remote Preconditioning of Trauma (RPCT) via Activation of Bradykinin Receptors (BK2R) and the Cytochrome P450 Epoxygenase Pathway in Canine Hearts
Garrett J. Gross et al.
CARDIOVASCULAR DRUGS AND THERAPY (2011)
Inflammasome Activation in Reperfusion Injury Friendly Fire on Myocardial Infarction?
Sebastian Grundmann et al.
CIRCULATION (2011)
Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
Masanori Kawaguchi et al.
CIRCULATION (2011)
Innate immune signaling in cardiac ischemia
Fatih Arslan et al.
NATURE REVIEWS CARDIOLOGY (2011)
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
Eleonora Mezzaroma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Interleukin-18 as a Predictor of Future Events in Patients With Acute Coronary Syndromes
Marianne Hartford et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
The IL-1 family: regulators of immunity
John E. Sims et al.
NATURE REVIEWS IMMUNOLOGY (2010)
The role of IL-1 in the pathogenesis of heart disease
Marcin Bujak et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Anakinra in Experimental Acute Myocardial Infarction-Does Dosage or Duration of Treatment Matter?
Fadi N. Salloum et al.
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury
Kaliyamurthi Venkatachalam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction
Meijing Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction
Antonio Abbate et al.
CIRCULATION (2008)
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure - The Rotterdam Study
GS Bleumink et al.
EUROPEAN HEART JOURNAL (2004)
Interleukin-18 and the risk of coronary heart disease in European men -: The Prospective Epidemiological Study of Myocardial Infarction (PRIME)
S Blankenberg et al.
CIRCULATION (2003)
Left ventricular remodeling after myocardial infarction - Pathophysiology and therapy
MGS Sutton et al.
CIRCULATION (2000)
分享论文
